Skip to main content
Steven Albelda, MD, Pulmonology, Philadelphia, PA

Steven M Albelda MD

Pulmonology•Philadelphia, PA

Critical Care Medicine, Pleural Disease

Professor, Medicine, Perelman School of Medicine

Join to View Full Profile

  • 3450 Hamilton Walk228 Stemmler HallPhiladelphia, PA 19104

  • Phone+1 215-573-9933

  • Fax+1 215-746-0376

Dr. Albelda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Albelda's Full ProfileAlready have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1985
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1979 - 1982
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1979

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1981 - 2018

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1995

Publications & Presentations

PubMed

Other

Press Mentions

  • Verismo Therapeutics Appoints Steven Albelda, MD, to Scientific Advisory Board
    Verismo Therapeutics Appoints Steven Albelda, MD, to Scientific Advisory BoardNovember 9th, 2021
  • Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for Mesothelioma
    Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for MesotheliomaSeptember 5th, 2019
  • Mesothelioma Clinical Trial Targets Latest Gene Therapy
    Mesothelioma Clinical Trial Targets Latest Gene TherapySeptember 4th, 2019
  • Join now to see all

Grant Support

  • Training In Pulmonary ImmunologyNational Heart, Lung, And Blood Institute2000–2011
  • Preclinical StudiesNational Cancer Institute2006–2010
  • Immuno/Immunogene Therapies For Thoracic MalignanciesNational Cancer Institute2006–2010
  • Genetic Influence On Incidence Of Acute Lung InjuryNational Heart, Lung, And Blood Institute2005–2009
  • AdministrationNational Cancer Institute2006
  • The Role Of Pecam In Models Of Lung InjuryNational Heart, Lung, And Blood Institute2002–2005
  • Gene Therapy For Malignant MesotheliomaNational Cancer Institute1995–2004
  • Vector Development /Preclinical TestingNational Cancer Institute2000–2002
  • Pecam And Calcium Signaling And TransmigrationNational Heart, Lung, And Blood Institute1999–2002
  • Ovarian Selective Adenoviral Vector For Gene Therapy Of Ovarian CancerNational Cancer Institute1999–2002
  • Efficacy And Mechanisms Of Ad.Rsvtk-Mediated Tumor Eradication--Disease ModelNational Cancer Institute1996–1999
  • Endocam/Pecam--A Novel Vascular Cell Adhesion MoleculeNational Heart, Lung, And Blood Institute1995–1999
  • Pilot Study--Model Of Human Bronchus To Study Gene Transfer In Cystic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1997
  • Competitive Supplement To Po1 CA 66726--Gene TherapyNational Cancer Institute1997
  • Human-Mouse Chimeras--A Model For Vascular Cell BiologyNational Heart, Lung, And Blood Institute1993–1997
  • Endocam/Pecam--A Novel Vascular Cell Adhesion MoleculeNational Heart, Lung, And Blood Institute1991–1994
  • Endothelial Cell-Blood InteractionsNational Heart, Lung, And Blood Institute1988–1989
  • Endothelial Cell - Blood InteractionsNational Heart, Lung, And Blood Institute1985–1987

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Steven Albelda, Dr. Steven Albelda, MD, Dr. S Albelda, Dr. Steven M Albelda